$ACT News Corner drug

New Post Public Reply Private Reply Replies (0) Message Board

May 6, 2014 at 11:36 AM

$ACT News

Corner drug store may move overseas to save on taxes
6:30 a.m. April 16, 2014
- Al Lewis

Intuitive Surgical slumps; Facebook extends rally
3:41 p.m. April 9, 2014
- Saumya Vaishampayan

Actavis acquires Silom Medical for $100 million
10:19 a.m. April 1, 2014
- MarketWatch.com

The 10 most overbought stocks in the S&P 500 index
12:19 p.m. March 25, 2014
- The Trading Deck

UK drug rejection, patent concerns take a bite out of Celgene shares

1:33 p.m. March 14, 2014
- blogs.marketwatch.com

Mylan to start selling generic Celebrex in May
7:22 a.m. March 13, 2014
- MarketWatch.com

Pfizer loses Celebrex patent ruling; shares halted but effect muted

3:21 p.m. March 12, 2014
- blogs.marketwatch.com

Staples awash in red; eBay up as Icahn posts new letter
4:09 p.m. March 6, 2014
- Victor Reklaitis

Icahn Enterprises reports profit up 144% in 2013
10:22 a.m. March 3, 2014
- MarketWatch

Citadel hedge fund’s recent moves
11:12 a.m. Feb. 25, 2014
- Insider Monkey

Stocks rally; S&P 500 ends right below record
4:45 p.m. Feb. 24, 2014
- Victor Reklaitis

U.S. stock market is starting to ride a tech M&A wave
5:31 a.m. Feb. 24, 2014
- Wallace Witkowski

Actavis continues hot streak with better-than-expected earnings

11:21 a.m. Feb. 20, 2014
- blogs.marketwatch.com

Actavis swings to loss on charges, write-downs
8:03 a.m. Feb. 20, 2014
- MarketWatch.com

Pharma megamergers bring higher profits, better returns, study says

1:59 p.m. Feb. 19, 2014
- blogs.marketwatch.com

Actavis, Forest shares continue their climb in aftermath of $25 billion deal

11:03 a.m. Feb. 19, 2014
- blogs.marketwatch.com

U.S. stocks edge up; Nasdaq gains for 8th day in a row
4:38 p.m. Feb. 18, 2014
- Anora Mahmudova

Forest Laboratories, Actavis surge on buyout deal
4:10 p.m. Feb. 18, 2014
- Ben Eisen

S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap

4:06 p.m. Feb. 18, 2014
- blogs.marketwatch.com

Forest buyout may not spell the end of dealmaking for Actavis

3:00 p.m. Feb. 18, 2014
- blogs.marketwatch.com

10-Q: ACTAVIS PLC
5:15 p.m. May 5, 2014
- Edgar Online - (EDG = 10Q, 10K)

Hottest Healthcare Stocks Now – HMSY ACAD ACT MWIV

1:45 p.m. May 5, 2014
- InvestorPlace.com

Best Five Stocks Over $100
10:07 a.m. May 3, 2014
- 247WallSt.com

AstraZeneca Nixes New Bid As Pfizer Woos British PM

1:11 p.m. May 2, 2014
- Investors Business Daily

Earnings Beat at Endo, Shares Up on Improved Outlook - Analyst Blog

12:10 p.m. May 2, 2014
- Zacks.com

Tyco Eyes 'Business Friendly' Ireland

8:35 a.m. May 2, 2014
- The Wall Street Journal Interactive Edition

What's With All The Healthcare And Pharmaceutical Mergers?

5:25 p.m. May 1, 2014
- TheStreet.com

Avanir Wins Lawsuit, Shares Up - Analyst Blog

4:39 p.m. May 1, 2014
- Zacks.com

A Look At World Stocks' Q1: Shire, Actavis, NXP Semi

4:32 p.m. May 1, 2014
- Investors Business Daily

Mylan Beats on Earnings, Misses on Sales - Analyst Blog

1:17 p.m. May 1, 2014
- Zacks.com

Company News for May 01, 2014 - Corporate Summary

10:06 a.m. May 1, 2014
- Zacks.com

Actavis plc (ACT): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report

8:00 a.m. May 1, 2014
- Zacks.com

Actavis PLC (ACT): Today's Featured Health Care Winner

5:00 p.m. April 30, 2014
- TheStreet.com

Actavis Beats Q1 Views, Looks To Supersized Future

4:28 p.m. April 30, 2014
- Investors Business Daily

Actavis Tops Q1 Earnings & Sales Estimates - Analyst Blog

4:25 p.m. April 30, 2014
- Zacks.com

Avanir up on patent case decision

2:55 p.m. April 30, 2014
- Seeking Alpha

Actavis Management Discusses Q1 2014 Results - Earnings Call Transcript

2:20 p.m. April 30, 2014
- Seeking Alpha

Actavis Q1 Earnings Beat On Generic Cymbalta Surprise

10:10 a.m. April 30, 2014
- Investors Business Daily

Zacks Rank #1 Additions for Wednesday - Tale of the Tape

9:30 a.m. April 30, 2014
- Zacks.com

Biggest Movers in Healthcare Stocks Now – ACT HSP FRX AZN

8:30 a.m. April 30, 2014
- InvestorPlace.com

Financial Results, Study Results, and Conference Schedules - Analyst Notes on Actavis, BMS, Baxter, Biogen Idec and AbbVie
9:00 a.m. Today9:00 a.m. May 6, 2014
- PR Newswire - PRF

Actavis and Forest Announce Effectiveness of Registration Statement
on Form S-4
9:02 a.m. May 5, 2014
- BusinessWire - BZX

Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4
9:00 a.m. May 5, 2014
- PR Newswire - PRF

Pfizer Expects $100 Billion Grab for AstraZeneca to Boost Pipeline
and Drop Tax Rate, an Industrial Info News Alert
6:31 a.m. April 30, 2014
- Marketwire

Stocks Close to Reporting their Earnings -- Research on Actavis, NYSE Community Bancorp, Hess, and Dominion Resources
4:36 a.m. April 30, 2014
- PR Newswire - PRF

Actavis Sues FDA Regarding Delay of Generic Celebrex® Approval
5:14 p.m. April 28, 2014
- PR Newswire - PRF

Strategic Collaborations, Fresh Agreements, and Upcoming Conferences - Analyst Notes on Biogen, Bristol-Myers, AbbVie, Actavis and Bard
8:00 a.m. April 28, 2014
- PR Newswire - PRF

Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts
8:00 a.m. April 25, 2014
- PR Newswire - PRF

Actavis Announces Celebrex® Patent Challenge Settlement
9:20 a.m. April 24, 2014
- PR Newswire - PRF

Actavis Announces Departure of G. Frederick Wilkinson, President, Actavis Global R&D
9:03 a.m. April 21, 2014
- PR Newswire - PRF

Actavis to Acquire Four Products from Akorn
4:15 p.m. April 17, 2014
- PR Newswire - PRF

Actavis and Forest Laboratories Receive FTC Second Request Under
Hart-Scott-Rodino
4:05 p.m. April 17, 2014
- BusinessWire - BZX

Actavis and Forest Laboratories Receive FTC Second Request Under Hart-Scott-Rodino
4:05 p.m. April 17, 2014
- PR Newswire - PRF

Actavis Announces Agreement Related to Generess® FE Patent Challenge Litigation
8:00 a.m. April 15, 2014
- PR Newswire - PRF

Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin
8:00 a.m. April 11, 2014
- PR Newswire - PRF

Pharma Equities under Review -- Research on Mylan, Actavis, Hospira, and Medicines
12:30 p.m. April 10, 2014
- PR Newswire - PRF

Actavis Launches Asia Pacific Regional Headquarters in Singapore
8:00 p.m. April 2, 2014
- PR Newswire - PRF

Particle Sciences and Actavis Enter into Joint Development Agreement
11:00 a.m. April 1, 2014
- PR Newswire - PRF

Actavis Acquires Silom Medical Company
8:30 a.m. April 1, 2014
- PR Newswire - PRF

Actavis Completes Divestiture of Commercial Operations in Seven Western European Countries to Aurobindo Pharma Limited
8:00 a.m. April 1, 2014
- PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IEHP's Wellness Center Launch Faces Delay in California

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

EFICYENT Ventures to Connect at Singapore FinTech Fest

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

SmallRig Boosts Art-Driven Innovation in AI Era

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Retirement Dreams Dashed: 61% Withdraw Early

By Olivia Taylor Updated Nov 14, 2026 Category News Views 183

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

AppLovin Legal Woes: A Deep Dive into Investor Claims

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...